Regional anesthesia

Preoperative posterior quadratus lumborum block: determining the minimum effective ropivacaine concentration in 90% of patients (minimum effective concentration (MEC90)) for postoperative analgesia after laparoscopic myomectomy

Anaesth Crit Care Pain MedPublished Dose-finding study

Authors' conclusion

The optimal concentration of ropivacaine for posterior QLB to achieve satisfactory analgesia following laparoscopic myomectomy is a 20 mL volume of 0.340% ropivacaine per side.

Study context

Population
Women scheduled for elective laparoscopic myomectomy under GA45 successful blocks
Participants
54 women
Comparison
Bilateral posterior quadratus lumborum block (QLB) with 20 mL ropivacaine per side at varying concentrations (biased coin design)
Outcome
MEC90 of ropivacaine for posterior QLB (block success: pain score ≤3 30 min after PACU arrival)
Follow-up
30 minutes after arrival in the PACU
Methodological detailsdouble-blind, comparative, biased coin up-and-down sequential allocation, Trial concluded at 45 successful blocks, Initial concentration 0.20%; after success, same (probability 0.89) or 0.05% lower (probability 0.11); after failure, 0.05% higher
  • Double-blind
  • Comparative
  • Biased coin up-and-down sequential allocation
  • Trial concluded at 45 successful blocks
  • Initial concentration 0.20%; after success, same (probability 0.89) or 0.05% lower (probability 0.11); after failure, 0.05% higher

Main finding

As reported in the abstract

MEC90 of ropivacaine

MEC90 of ropivacaine

0.340%

95% CI 0.329 to 0.344%

Original publication

Preoperative posterior quadratus lumborum block: determining the minimum effective ropivacaine concentration in 90% of patients (MEC90) for postoperative analgesia after laparoscopic myomectomy. Anaesth Crit Care Pain Med. Published 20 January 2025. doi:10.1016/j.accpm.2025.101480

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.